Polymyxin B-Induced Diffuse Cutaneous Hyperpigmentation
نویسندگان
چکیده
منابع مشابه
Lichenoid type cutaneous hyperpigmentation induced by nebivolol.
Cutaneous hyperpigmentation is a common and well-defined side effect of many drugs, such as non-steroidal anti-inflammatory drugs, beta-blockers, and tetracyclines, but to the best of our knowledge there is no case of skin discoloration related to nebivolol in the literature. Presently described is lichenoid type cutaneous hyperpigmentation in a 46-year-old female patient. Hyperpigmentation eme...
متن کاملMinocycline-Induced Cutaneous Hyperpigmentation in an Orthopedic Patient Population
Background. The objectives of this study were to estimate the incidence and evaluate risk factors for development of minocycline-induced cutaneous hyperpigmentation in patients with orthopedic infections. Methods. Patients with orthopedic infections evaluated at Mayo Clinic (Rochester, MN) and treated with minocycline from 1 January 2002 to 31 December 2011 were retrospectively identified. Lo...
متن کامل706Minocycline-Induced Cutaneous Hyperpigmentation in an Orthopedic Patient Population
Background. Patients on chronic minocycline suppression for orthopedic infections at a single institution were studied for development of minocycline-induced cutaneous hyperpigmentation and analysis of risk factors. Methods. This is a retrospective cohort study of Mayo Clinic patients with hardware or non-hardware associated chronic orthopedic infections treated with long termminocycline suppre...
متن کاملCutaneous hyperpigmentation induced by doxycycline: a case series.
Cutaneous hyperpigmentation is a well-known side effect of tetracyclines, but doxycycline-induced cutaneous hyperpigmentation has only been described in one patient with a therapeutic dosage of doxycycline, and in one patient using suprapharmacological doses. We describe four patients with cutaneous hyperpigmentation in previously unaffected skin, and speculate that this was due to treatment wi...
متن کاملCutaneous diffuse large B‐cell lymphoma
Cutaneous diffuse large B-cell lymphoma accounts for ~6% of all cutaneous lymphomas. It is associated with poor prognosis, and solitary lesions are relatively rare. It often requires an aggressive approach with multi-agent chemotherapy and radiotherapy. It is important to recognize these cases in order to offer rapid and appropriate management.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
سال: 2017
ISSN: 2249-782X
DOI: 10.7860/jcdr/2017/24278.9213